Step Therapy Requirements. Effective: 03/01/2015

Similar documents
VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

ANTICONVULSANTS. Details

Step Therapy Requirements

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

FirstCarolinaCare Insurance Company Step Therapy Requirements

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTIDIABETIC AGENTS - MISCELLANEOUS

Step Therapy Requirements. Effective: 1/1/2019

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements. Effective: 05/01/2018

Step Therapy Requirements. Effective: 12/01/2016

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

2017 Step Therapy Criteria

ALLERGIC CONJUNCTIVITIS AGENTS

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

ALPHA GLUCOSIDASE INHIBITOR THERAPY

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

ANTICONVULSANT STEP THERAPY

2019 PDP Basic Step Therapy Document

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

ADHD STIMULANTS-S(SHC)

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

Step Therapy Medications

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

2019 Simply Step Therapy Document

2018 Step Therapy Criteria

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

SmithRx Standard Formulary Step Therapy List

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

ANTICONVULSANT THERAPY

Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: Version 26 Updated: 11/1/2016

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE

Ohana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs)

ADHD STIMULANTS - SCORE

STEP THERAPY ALGORITHMS PUP Select Formulary

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

ADHD STIMULANTS - SCORE

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Step Therapy Criteria

ATYPICAL ANTIPSYCHOTICS

Texas Prior Authorization Program Clinical Edit Criteria

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Medications and Children Disorders

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

Avoid paying too much for your prescriptions

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

**CRITERIA UNDER CMS REVIEW**

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY

Alaska Medicaid 90 Day** Generic Prescription Medication List

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

CONTRAINDICATIONS TABLE

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

2019 STEP THERAPY CRITERIA UCare Individual & Family Plans UCare Individual & Family Plans with Fairview

Step Therapy Group. Atypical Antipsychotic Agents

Blue Medicare HMO Essential 2015 Quantity Limit List Blue Medicare Rx Standard 2015 Quantity Limit List

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

May 2017 P&T Updates

Medications, By Class, in TBI

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

Antiepileptics. Medications Comment Quantity Limit Carbamazepine. May be subject Preferred to quantity limit Epitol

AGGRENOX. Products Affected. Details. GRP B2 Last Updated: 09/01/2018. Aggrenox

STEP THERAPY CRITERIA

Drugs That Require Step Therapy (ST) Step Therapy Medications

Non-Opioid Drugs to Treat Neuropathic Pain. March 2018

Transcription:

Effective: 03/01/2015 Updated 02/2015

ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS.

ANTICONVULSANTS APTIOM BANZEL FYCOMPA OXTELLAR XR POTIGA QUDEXY XR TROKENDI XR VIMPAT PRIOR CLAIM FOR GENERIC ANTICONVULSANT AGENT (CARBAMAZEPINE, DIVALPROEX SODIUM, GABAPENTIN, LAMOTRIGINE, LEVETIRACETAM, OXCARBAZEPINE, TIAGABINE, TOPIRAMIDE, VALPROIC ACID, VALPROATE, OR ZONISAMIDE) WITHIN THE PAST 120 DAYS.

ANTIDIABETIC AGENTS - MISCELLANEOUS INVOKAMET INVOKANA JARDIANCE PRIOR CLAIM FOR METFORMIN, METFORMIN ER, A SULFONYLUREA, A COMBINATION OF SULFONYLUREA AND METFORMIN, PIOGLITAZONE, A COMBINATION OF PIOGLITAZONE AND METFORMIN, OR A COMBINATION OF PIOGLITAZONE AND GLIMEPIRIDE IN THE LAST 120 DAYS.

ANTIPSYCHOTIC AGENTS CLOZAPINE ODT FANAPT FAZACLO INVEGA LATUDA SAPHRIS VERSACLOZ PRIOR CLAIM FOR FORMULARY VERSIONS OF ANTIPSYCHOTICS RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, OR ZIPRASIDONE, AND ABILIFY WITHIN THE PAST 365 DAYS.

B VERSUS D ADMINISTRATIVE STEP CYCLOPHOSPHAMIDE METHOTREXATE TREXALL IN ORDER TO ASSIST IN A PART B VS. D PAYMENT DETERMINATION, A PRIOR CLAIM SEEN FOR A RHEUMATOID ARTHRITIS DRUG WITHIN THE PAST 120 DAYS WILL QUALIFY FOR PART D PAYMENT. ALL OTHER INDICATIONS WILL HAVE A PART B VS. D PAYMENT DETERMINATION MADE THROUGH THE FORMULARY EXCEPTION PROCESS PRIOR TO THE APPROVAL OF THE DRUG.

CONTRACEPTIVES NUVARING PRIOR CLAIM FOR A GENERIC ORAL 21 OR 28 DAY CONTRACEPTIVE WITHIN THE PAST 120 DAYS. DOES NOT INCLUDE PLAN B OR PLAN B-ONE STEP OR THEIR GENERICS.

HYPERURICEMIC AGENTS ULORIC PRIOR CLAIM FOR ALLOPURINOL OR COLCHICINE WITHIN THE PAST 120 DAYS

MULTIPLE SCLEROSIS AGENTS AVONEX AVONEX ADMINISTRATION PACK BETASERON EXTAVIA PLEGRIDY PLEGRIDY PEN PRIOR CLAIM FOR REBIF (INTERFERON BETA-1A) OR COPAXONE (GLATIRAMIR ACETATE) WITHIN THE PAST 120 DAYS.

OPHTHALMIC ANTIHISTAMINES PATADAY PATANOL PRIOR CLAIM FOR LEVOCETIRIZINE OR CROMOLYN SODIUM EYE DROPS WITHIN THE PAST 120 DAYS.

QUETIAPINE FUMARATE EXTENDED RELEASE SEROQUEL XR PRIOR CLAIM FOR FORMULARY VERSIONS OF ATYPICAL ANTIPSYCHOTICS RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, OR ZIPRASIDONE, OR A SSRI OR SNRI CITALOPRAM, FLUOXETINE, PAROXETINE, SERTRALINE, OR VENLAFAXINE, AND ABILIFY WITHIN THE PAST 365 DAYS.

RENIN ANGIOTENSION SYSTEM INHIBITORS AZOR BENICAR BENICAR HCT DIOVAN EXFORGE EXFORGE HCT TRIBENZOR PRIOR CLAIM FOR AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACE INHIBITOR), OR ACE INHIBITOR COMBINATION OR A GENERIC ANGIOTENSIN RECEPTOR BLOCKER (ARB), OR GENERIC ARB COMBINATION WITHIN THE PAST 120 DAYS.

RIFAXIMIN XIFAXAN PRIOR CLAIM FOR LACTULOSE WITHIN THE PAST 120 DAYS.

ROTIGOTINE NEUPRO PRIOR CLAIM FOR IMMEDIATE RELEASE PRAMIPEXOLE OR IMMEDIATE RELEASE ROPINIROLE WITHIN THE PAST 120 DAYS.

SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIBITORS (SNRIS) BRINTELLIX FETZIMA KHEDEZLA PRISTIQ ER PRIOR CLAIM FOR PAROXETINE, FLUOXETINE, SERTRALINE, CITALOPRAM, MIRTAZAPINE, ESCITALOPRAM, OR BUPROPION (IR, SR, XL) WITHIN THE PAST 120 DAYS.